Sandip Kapadia - Mar 29, 2023 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Signature
/s/ Christian Ulrich, Attorney-in-Fact
Stock symbol
HRMY
Transactions as of
Mar 29, 2023
Transactions value $
-$514,211
Form type
4
Date filed
3/31/2023, 04:26 PM
Previous filing
Dec 2, 2022
Next filing
May 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRMY Common Stock Options Exercise $0 +30K $0.00 30K Mar 29, 2023 Direct
transaction HRMY Common Stock Tax liability -$514K -15.4K -51.38% $33.36 14.6K Mar 29, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRMY Restricted Stock Units Options Exercise $0 -30K -50% $0.00 30K Mar 29, 2023 Common Stock 30K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
F2 This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023. 25% of the underlying shares are scheduled to vest on each of March 29, 2024 and March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.